Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

Clinical trial NCT02178722 · COMPLETED

Trial details

NCT number: NCT02178722
Sponsor: Incyte Corporation
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Microsatellite-instability (MSI) High Colorectal Cancer (CRC)Endometrial Cancer Head and Neck Cancer Hepatocellular Carcinoma (HCC)Gastric Cancer Lung Cancer Lymphoma Renal Cell Carcinoma (RCC)Ovarian Cancer Solid Tumors UC (Urothelial Cancer)Melanoma

Start date: 2014-07-17
Primary completion: 2018-11-26
Enrollment: 444

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.